Unlock instant, AI-driven research and patent intelligence for your innovation.

FSHR (follicle-stimulating hormone receptor)-targeted tumor treatment polypeptide and application thereof

A tumor treatment, targeting technology, applied in the field of biomedicine

Active Publication Date: 2015-09-23
JIANGSU INST OF NUCLEAR MEDICINE
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is a lack of fusion polypeptide proteins with both FSHR targeting and stronger anti-tumor functions in the prior art

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • FSHR (follicle-stimulating hormone receptor)-targeted tumor treatment polypeptide and application thereof
  • FSHR (follicle-stimulating hormone receptor)-targeted tumor treatment polypeptide and application thereof
  • FSHR (follicle-stimulating hormone receptor)-targeted tumor treatment polypeptide and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] Detecting the expression of FSHR in several kinds of cells by Western Blot

[0058] Human prostate cancer cell line PC3, human cervical cancer cell line Hela, human ovarian cancer cell line SKOV3, human breast cancer cell line MCF7, human embryonic kidney cell 293, and mouse fibroblast L929 were purchased from the Shanghai Cell Bank of the Chinese Academy of Sciences.

[0059] Male BALB / c-nu nude mice, weighing 18-19 g, were purchased from Jiangsu Changzhou Cavens Experimental Animal Co., Ltd., SPF grade, and aged 5 weeks. Certificate number: NO.0026328, license number: SCXK (Su) 2011-0003.

[0060] The cell culture methods of PC3, MCF7, Hela, PC3, 293, SKOV3, and L929 used in the experiment were the same, at 37°C, 5% CO 2 Cultured and subcultured in a constant temperature incubator, cultured with DMEM medium containing 10% fetal bovine serum, 100U / ml penicillin, and 100U / ml streptomycin.

[0061] Collect cells, use RIPA reagent containing protease inhibitors, extract...

Embodiment 2

[0065] Determination of peptide FSH by MTT method 33-53 -The effect of IIKK on the viability of various cells

[0066] Cells grown in logarithmic phase were divided into 5×10 3 The density of cells / well was seeded in a 96-well plate. After culturing overnight, after the cells adhered to the wall, each well was added with different concentrations of FSH 33-53 - 100 μl of culture medium of IIKK, IIKK and cisplatin (concentration gradient is 0, 1, 2, 5, 10, 15, 20, 40, 50 μM), and three replicate wells are set for each concentration. After incubation for 24 hours, add 40 μl of MTT solution with a concentration of 2 mg / ml to each well and continue culturing, and discard the supernatant after 4 hours; add 150 μl of DMSO to each well and shake for 10 minutes to fully dissolve the crystals. A microplate reader was used to measure the OD value of the sample at a wavelength of 570 nm. Calculate the survival rate, draw the survival curve, and find the IC 50 . Survival rate=(OD val...

Embodiment 3

[0074] FSH 33-53 - Effect of IIKK on PC3 cell cycle

[0075] The cell cycle refers to the activity process of cells from the end of the previous division to the end of the next division, which is divided into two stages: interphase and division phase. Among them, the interphase is divided into G1 phase (pre-DNA synthesis), S phase (DNA synthesis phase), and G2 phase (late DNA synthesis phase). M phase is the mitotic phase. The G0 phase is the cell dormancy phase. Propidium iodide (PI) is a nuclear staining reagent that can stain DNA and RNA, and can release red fluorescence after intercalating DNA or RNA. Although PI cannot pass through the living cell membrane, it can pass through the damaged cell membrane and stain the nucleus. Cold ethanol can increase cell membrane permeability. RNA is cleaved with RNase, allowing PI to enter the cell and selectively bind to DNA. The fluorescence of the dye in the cell is proportional to the DNA content in the nucleus. The relative D...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides FSHR (follicle-stimulating hormone receptor)-targeted tumor treatment polypeptide and an application thereof. Polypeptide has an FSHR-targeted tumor treatment effect, the FSHR-targeted tumor treatment polypeptide is FSH33-53-IIKK-targeted fusion polypeptide, and the polypeptide has anti-tumor activity of enhanced IIKK polypeptide. The FSH33-53-IIKK-targeted fusion polypeptide can be applied to the preparation of drugs for treating or preventing tumors.

Description

technical field [0001] The invention belongs to the field of biomedicine, and relates to a tumor treatment polypeptide with FSHR targeting and application thereof. technical background [0002] Follicle-stimulating hormone receptor (FSHR) is a potential prostate cancer targeting marker. FSHR is a membrane receptor composed of oligomeric glycoproteins and belongs to the family of G protein-coupled receptors. FSHR mainly exists in the Sertoli cells and ovarian granulosa cells of human and animal testes, and affects the initiation of male puberty spermatogenesis, the maintenance of adult spermatogenesis and the development of female egg cells at various stages by mediating the signal of follicle stimulating hormone (FSH). 2010 New England Journal of Medicine (Radu A, Pichon C, CamparoP, et al. Expression of follicle-stimulating hormone receptor in tumor blood vessels. N Engl J Med. 2010 Oct 21; 363(17): 1621-30.) It was reported that 1336 cases of different tumor specimens we...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K19/00C07K14/59A61K38/24A61P35/00
Inventor 杨敏杨润琳潘栋辉徐宇平严骏杰王立振赵富宽张波
Owner JIANGSU INST OF NUCLEAR MEDICINE